{"description":"Adverse event data not applicable for this study","eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":0,"description":"Patients in this group signed consent, met eligibility criteria, and all had ALK-positive cancer of a primary lung lesion with systemic progression (excluding the central nervous system)","id":"EG000","otherNumAffected":0,"otherNumAtRisk":0,"seriousNumAffected":0,"seriousNumAtRisk":0,"title":"ALK-positive NSCLC With Progression"}],"frequencyThreshold":"0","timeFrame":"Adverse event data not applicable for this study"}